|
Rowen Region ReadyRowen stands at the forefront of Georgia’s future growth. This 11-county area is expected to generate 43% of the state’s population increase by 2050, and it will provide nearly half of Georgia’s prime working-age talent. Notably, 85-95% of people who move to the Rowen Region remain in the region year after year, highlighting its strong retention and desirability. Thanks to strong college graduation rates and a well-educated workforce, Rowen is rapidly gaining recognition as the prime location for industries like healthcare, technology, and engineering. It’s clear—Rowen is uniquely situated to drive progress across Georgia. Learn How Rowen Drives Georgia’s Economic Future
Rooted in RowenRowen’s Living Lab projects transform the campus into a collaborative laboratory for students, researchers and industry leaders to advance research, innovate and create a sustainable impact. Here’s what we’ve been up to:
Looking ahead to 2026, these projects are expected to progress even more as new research phases, experiential learning opportunities and industry partnerships are introduced. Learn More About Rowen Living Labs
Rowen in the MediaIn 2025, Rowen was featured in 20 articles spanning more than 10 media outlets, demonstrating the distinctiveness and significance of Rowen’s mission.
Discover More News and Media
Rowen on the RoadRowen hit the road like never before in 2025. We joined over 70 events, sponsoring more than 10, across six U.S. states and two countries (Germany and Sweden). Each trip strengthened connections, raised awareness and showcased Rowen as a top destination for business growth. Where can you find us next?
The Science of Art in Discovery, Research and Innovation |
Newsletters
Rowen’s First Tenant is a Win for Georgia’s Future UCB, a global biopharmaceutical company focused on treatments for severe neurological and autoimmune conditions, has selected Rowen as the site of its new U.S. biologics manufacturing campus — bringing $2 billion in direct investment, more than 330 permanent jobs and approximately $5 billion in total economic impact. For everyone who has […]
Newsletters
UCB Selects Rowen for $2B Biopharma Manufacturing Campus First tenant milestone validates Rowen’s innovation community model and signals the establishment of a new life sciences hub in Georgia Global biopharmaceutical company UCB has selected Rowen as the site of its new U.S. biologics manufacturing campus: a $2 billion direct investment expected to create more than 330 permanent jobs and generate approximately $5 […]
Announcements
First tenant milestone validates Rowen’s innovation community model and signals the start of a new life sciences hub in Gwinnett County.